ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mitochondrial-Targeted Triphenylphosphonium-Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation

Zhang, Kunfeng; Fu, Jingxin; Liu, Xiaorui; Guo, Yifei; Han, Meihua; Liu, Meifeng*; Wang, Xiangtao*河北医科大学; 中国医学科学院; 中国医学科学院北京协和医院
Pharmaceutics2023-2DOI: 10.3390/pharmaceutics15020388
2被引12阅读
引用收藏
分享

摘要

Mitochondria are involved in various stages of cancer cell diffusion and metastasis. Therefore, targeting tumor mitochondria with antineoplastic medicines to cause mitochondria to initiate apoptosis may be an effective strategy for cancer therapy. Here, in order to enhance the anti-tumor efficacy of the antineoplastic agent hydroxycamptothecin (HCPT), the mitochondrial targeting ligand 4-(carboxybutyl) triphenylphosphine bromide (TPP) was attached to HCPT by an ester linkage. The resultant TPP-HCPT (TH) conjugate could self-assemble into nano-aggregates, with a mean particle size of 203.2 nm and a polydispersity index (PDI) value of 0.312. The TH conjugate could also co-assembly with mPEG(3000)-PLGA(5000) into nanoparticles (TH-NPs), with a mean diameter of 86.41 nm, a PDI value of 0.256 and a zeta potential of -0.125 mV. In contrast to HCPT injections, TH aggregates displayed enhanced cellular uptake, mitochondria-targetability and cytotoxicity against 4T1 cells, while TH-NPs showed even better improvement than TH aggregates. In the in vivo study, TH aggregates displayed higher anti-tumor efficacy in 4T1 tumor-bearing mice than HCPT injections (tumor inhibition rate, 55.71% vs. 69.17%), and TH-NPs displayed more superior anti-tumor effects (tumor inhibition rate, 80.02%). In conclusion, our research demonstrated that the TPP-HCPT conjugate and its nano-formulations, including TH aggregates and TH-NPs, may be a promising mitochondria-targeting anticancer medicine for cancer therapy. As far as we know, this is the first report in which TPP and HCPT have been conjugated directly for this aim.

学科与关键词

关键词
mitochondrial targetinghydroxycamptothecintriphenylphosphinenanoparticles
相关
加载中…
  • Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin
    Xie, Jiacui; Wang, He; Huang, Qiudi; Lin, Jiachang; Wen, Huaying; Miao, Yingling; Lv, Le; Ruan, Dongxue; Yu, Xiyong; Qin, Linghao*; Zhou, Yi*European Journal of Pharmaceutical Sciences, 2023, 189: 106561.被引 1
  • Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy
    Gu, Liwei; Zhang, Jiaxing; Liu, Dandan; Chen, Jiayun; Liu, Shuzhi; Peng, Qing; Tian, Ya; Du, Maobo; Zhang, Junzhe; Xiao, Wei; Shen, Shuo*; Wang, Jigang*JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20(1): 376.被引 8
  • Design and development of a mitochondrial-targeted photosensitizer for two-photon fluorescence imaging and photodynamic therapy
    Chen, Yu; Zhang, Sheng; Cheng, Tianjiao; Lin, Wei; Mao, Linlin; Chen, Zhonghui; Yang, Yang; Huang, Hanqing; Li, Jinqiu*; Ke, Zhiyong*; Cui, Zhong-Kai*JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY, 2023, 141: 135-148.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmaceutics
发表日期
2023-02
卷期
第 15 卷, 第 2 期
页码
388
DOI
10.3390/pharmaceutics15020388
成果收录
SCIE
资助标注
CAMS Innovation Fund for Medical Sciences (CIFMS) [2021-I2M-1-071]; Program for Guangdong YangFan Introducing Innovative and Entrepreneurial Teams [2017YT05S029]

作者

  • Z

    Zhang, Kunfeng (第一作者)

    henan univ

  • F

    Fu, Jingxin

    chinese acad med sci · inst med · peking union med coll

查看全部 7 位作者收起作者
  • L

    Liu, Xiaorui

    chinese acad med sci · inst med · peking union med coll

  • G

    Guo, Yifei

    chinese acad med sci · inst med · peking union med coll

  • H

    Han, Meihua

    chinese acad med sci · inst med · peking union med coll

  • L

    Liu, Meifeng (通讯)

  • W

    Wang, Xiangtao (通讯)

    henan univ · chinese acad med sci · inst med · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417